Abstract
1. The effect of p-chlorophenoxyisobutyrate (CPIB) on glucose metabolism human skin fibroblasts was examined. 2. CPIB increased the incorporation of 2-deoxy-D-[U-14C]glucose into skin fibroblasts. 3. CPIB decreased [14C]CO2 production from D-[U-14C]glucose but did not affect pyruvate dehydrogenase activity. 4. CPIB reduced fatty acid oxidation activity and cholesterol synthesis but increased triglyceride synthesis. 5. These effects of CPIB were observed both in the presence and in the absence of insulin. 6. One possible mechanism of CPIB on reducing plasma glucose may be due to the increase of glucose incorporation into the cells and triglyceride synthesis in the cells.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BEST M. M., DUNCAN C. H. REDUCTION OF SERUM TRIGLYCERIDES AND CHOLESTEROL BY ETHYL P-CHLOROPHENOXY-ISOBUTYRATE (CPIB). Am J Cardiol. 1965 Feb;15:230–233. doi: 10.1016/0002-9149(65)90459-5. [DOI] [PubMed] [Google Scholar]
- Barnett D., Craig J. G., Robinson D. S., Rogers M. P. Effect of clofibrate on glucose tolerance in maturity onset diabetes. Br J Clin Pharmacol. 1977 Aug;4(4):455–458. doi: 10.1111/j.1365-2125.1977.tb00761.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- FOLCH J., LEES M., SLOANE STANLEY G. H. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957 May;226(1):497–509. [PubMed] [Google Scholar]
- Fenderson R. W., Jr, Sekowski I., Mohan C., Deutsch S., Benjamin F., Samuel P. Effect of clofibrate on plasma glucose and serum immunoreactive insulin in patients with hyperlipoproteinemia. Am J Clin Nutr. 1974 Jan;27(1):22–28. doi: 10.1093/ajcn/27.1.22. [DOI] [PubMed] [Google Scholar]
- Ferrari C., Frezzati S., Romussi M., Bertazzoni A., Testori G. P., Antonini S., Paracchi A. Effects of short-term clofibrate administration on glucose tolerance and insulin secretion in patients with chemical diabetes or hypertriglyceridemia. Metabolism. 1977 Feb;26(2):129–139. doi: 10.1016/0026-0495(77)90048-8. [DOI] [PubMed] [Google Scholar]
- Ip C., Tepperman H. M., Tepperman J. Effect of p-chlorophenoxyisobutyrate on the antilipolytic action of insulin and insulin binding in isolated adipocytes. J Lipid Res. 1976 Jan;17(1):68–73. [PubMed] [Google Scholar]
- LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
- Morisaki N., Saito Y., Kumagai A. Fatty acid oxidation of rat brain microvessels in hypertension, aging and experimental diabetes. Atherosclerosis. 1982 Apr;42(2-3):221–227. doi: 10.1016/0021-9150(82)90152-6. [DOI] [PubMed] [Google Scholar]
- Oram J. F., Albers J. J., Cheung M. C., Bierman E. L. The effects of subfractions of high density lipoprotein on cholesterol efflux from cultured fibroblasts. Regulation of low density lipoprotein receptor activity. J Biol Chem. 1981 Aug 25;256(16):8348–8356. [PubMed] [Google Scholar]
- Saltiel A. R., Siegel M. I., Jacobs S., Cuatrecasas P. Putative mediators of insulin action: regulation of pyruvate dehydrogenase and adenylate cyclase activities. Proc Natl Acad Sci U S A. 1982 Jun;79(11):3513–3517. doi: 10.1073/pnas.79.11.3513. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Skipski V. P., Smolowe A. F., Sullivan R. C., Barclay M. Separation of lipid classes by thin-layer chromatography. Biochim Biophys Acta. 1965 Oct 4;106(2):386–396. doi: 10.1016/0005-2760(65)90047-0. [DOI] [PubMed] [Google Scholar]